Research Antibodies & Reagents Market

Research Antibodies & Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western blotting, Flow Cytometry), Application (Proteomics, Drug Development), End User - COVID-19 Impact - Global Forecast to 2025

Report Code: BT 5482 Oct, 2020, by marketsandmarkets.com

[278 Pages Report] The research antibodies and reagents market is projected to reach USD 14.1 billion by 2025 from USD 10.1 billion in 2020, at a CAGR of 6.7% during the forecast period. The research antibodies and reagents market has evolved owing to factors such as growth in proteomics and genomics research, rising demand for high-quality antibodies for research reproducibility, and increasing R&D activity and expenditure in the life sciences industry. Fueled by the growing demand for personalized medicine and structure-based drug design, the global research antibodies and reagents market is expected to witness significant growth in the coming years.

Research Antibodies & Reagents Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 Impact on Global Research Antibodies and Reagents Market

The COVID-19 outbreak has boosted research activity due to efforts to understand the dynamics of the infection. We estimate that the major share of research antibody and reagent manufacturing, along with personalized medicine, will grow at a stable pace in the next five years. Due to the increase in research activity, both the availability of funding for research and the demand & manufacturing of reagents and antibodies are expected to grow.

Because of the pandemic, companies have scaled up their operations for testing and tracking the infection of COVID-19. This has given a chance for growth in profits for companies operating in the NGS and PCR markets. The growth in revenue is 5–7%, as COVID-19 testing has increased with the use of the latest technology of genetic and molecular testing. The shift in demand for research for COVID-19, neurobiology, and oncology has created a huge scope for testing solutions, such as western blotting, flow cytometry, ELISA, and drugs for researchers and laboratories.

The shift in demand toward relevant technology has forced key players operating in the market to strategize their manufacturing capabilities, focus on new product development, and provide optimum supply chain strategies concentrated towards COVID-19 essentials. According to our findings, the research antibodies and reagents market is expected to grow at an approximate CAGR of 9–11% for the next two years. The factors listed below would play a key role in shaping the growth of the global market:

  • With the increased demand for faster testing and research being conducted in the field, the demand for research antibodies and reagent technologies has also increased, especially in the areas of ELISA, flow cytometry, immunohistochemistry, and PCR. The FDA has approved various oncology profiling tests such as PCR testing panels and drugs for emergency use in COVID-19 testing and diagnostics.
  • The outbreak of COVID-19 has been increasing at an exponential level in the US. This has led to a decline in regular patient visits to hospitals and clinics and the number of profiling studies being conducted under normal circumstances. This is expected to inhibit market growth to a certain extent.
  • Due to the rapid spread of COVID-19, medical supplies and equipment may run short. This is attributed to the lockdown of manufacturing sites in areas affected by COVID-19 or travel restrictions impacting shipments. Beyond transportation-related delays arising from travel restrictions and some driver shortage issues, COVID-19 has not hugely impacted the supplies of raw materials for research antibodies and reagent technologies.
  • The global economy is expected to normalize by Q1 2021, which will increase the number of diagnostic procedures conducted (which, because of the pandemic, were kept on hold).

Research Antibodies and Reagents Market Dynamics

Driver:  Increasing research activities and funding for R&D

The R&D sector has conventionally remained capital-intensive due to long development periods and approval cycles. R&D investments occupy a prime position in global expenditure. Governments recognize R&D as a crucial aspect of a nation’s progress, international competitiveness, and public benefit. Due to this, R&D expenditure and funding have witnessed a steady increase over the years

Restraint: Quality concerns and a lack of reproducible results

Variations in antibody production techniques have resulted in a lack of reproducibility of results. There are no standards for their validation nor agreed-upon definitions of reproducibility across all antibody offerings. The lot-to-lot variability of these antibodies significantly affects the results of basic research and clinical screening tests. Thus, variations in the quality of antibodies are a major driver of what has been deemed a reproducibility crisis—a growing realization that the results of many biomedical experiments cannot be reproduced and that conclusions based on them may be unfounded. As described in many publications, months’ or even years’ worth of research has been shown to be incorrect or irreproducible, resulting in lost time, retracted publications, and astounding amounts of funds spent on projects that ended up stalled or abandoned.

Opportunity: Emerging Markets

The Asia Pacific region is expected to offer potential growth opportunities to market players in the coming years, due to the diversified healthcare markets in this region, the growing incidence of infectious and chronic disorders, and increasing R&D initiatives to develop innovative proteomic and genomic techniques. Regulatory policies in Asia are also more adaptive and business-friendly, which serves to attract the attention of large corporations already facing increasing competition in mature markets.

Challenge:  Cost and time-intensive antibody development processes

The development of monoclonal or polyclonal antibodies is a time-intensive and complex procedure, as it requires certain considerations such as the antigen against which antibodies need to be generated, specificity and sensitivity, and reproducibility. Besides, the technologies required for antibody production include large bioreactors, chromatography resins, filtration systems, and media and buffers for upstream processing, downstream processing, and purification. Such operations require high capital investment, making the entire procedure cost intensive. Moreover, the average time required for the development of a specific mAb is over five months.

The reagent segment accounts for the largest share of the market, by technology, in 2019

Based on product, the research antibodies and reagents market are segmented into reagent and antibodies. The reagent segment accounted for the larger market share in 2019. The reagents market is experiencing notable growth due to the growing applications of biosciences and biotechnology within the pharmaceutical and healthcare fields.

The primary antibodies segment accounts for the largest share of the market, by type, in 2019

Based on antibodies product type, the research antibodies and reagents market are segmented into reagents and antibodies. This segment is witnessing a strong growth due to the use of these antibodies in numerous types of assay formats. Their accuracy in biomarker detection and their high specificity and sensitivity are also driving their adoption.

The media & sera segment accounts for the largest share of the market, by type, in 2019

Based on reagent product type, the media & sera segment held the largest share of the global research reagents market in 2019. The large share of this segment is primarily attributed to the use of these components in all types of assays, cell cultures, and techniques.

The flow cytometry segment is expected to grow at the highest CAGR during the forecast period

Based technology, the research antibodies and reagents market is segmented into western blotting, flow cytometry, ELISA, Immunohistochemistry, Immunofluorescence, Immunoprecipitation, and other technologies. The flow cytometry segment is expected to witness the highest growth during the forecast period. This is mainly due to this technique is its ability to perform simultaneous multi-parameter analysis on single cells within a heterogeneous mixture. It offers high throughput and the automated quantification of cell features. These factors, along with technological innovations in flow cytometry and growing cancer research, are driving the growth of this segment.

The proteomics segment accounts for the largest share of the market, by application, in 2019

Based on application, the research antibodies and reagents market is segmented into proteomics, drug development and Genomics. Proteomics held the largest share of the global research antibodies and reagents market in 2019.The growth of the segment is due to as it efficiently maps drug-protein and protein-protein interactions. Moreover, proteomic technologies have minimized the cost, time, and resource requirements for chemical synthesis and biological testing of drugs. Proteomic technologies, such as electrophoresis, ELISA, microarrays, and MS-based proteomics, are highly efficient for analytical laboratory testing.

The pharmaceutical & biotechnology companies segment accounts for the largest share of the market, by end-user, in 2019

The research antibodies and reagents market is segmented into the pharmaceutical & biotechnology companies, academic & research institutions and Contract Research Organizations. The pharmaceutical & biotechnology companies held the largest share of the global research antibodies and reagents end-user market in 2019. The large share of this segment is attributed to the wide use of research antibodies in drug development for the identification and quantification of biomarkers and various analytical procedures.

Research Antibodies & Reagents Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The North America market accounts for largest market share for research antibodies and reagents market in 2019

North America held the largest share of the global research antibodies and reagents market. The region is growing due to investments for the development of structure-based drug designs, growing research in the fields of genomics and proteomics, and the focus of stakeholders on research projects involving proteins, associated biomolecules, and genes are the key driving factors of the market in North America

Key Market Players

The prominent market players are Thermo Fisher Scientific (US), Merck Group (Germany), Abcam plc (UK), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Cell Signaling Technology (US), F. Hoffmann-La Roche (Switzerland), Danaher Corporation (US), Agilent Technologies (US), PerkinElmer (US), Lonza (Switzerland), GenScript (China), and BioLegend (US).

Report Metric

Details

Market size available for years

2018–2025

Base year considered

2019

Forecast period

2020–2025

Forecast units

Value (USD Billion)

Segments covered

Product, Technology, Application, End User

Geographies covered

North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa

Companies covered

Thermo Fisher Scientific (US), Merck Group (Germany), Abcam plc (UK), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Cell Signaling Technology (US), F. Hoffmann-La Roche (Switzerland), Danaher Corporation (US), Agilent Technologies (US), PerkinElmer (US), Lonza (Switzerland), GenScript (China), BioLegend (US), Illumia (US), ImmonoPresice Antibodies (Canada), Fujirebio (Sweden), Analytik Jena AG (Germany), Omega BioTek (US), Dovetail Genomics (US) and Atlas Antibodies (Sweden)

The study categorizes the Research Antibodies and Reagents market based on product, technology, application, end User and regional and global level.

Global Research Antibodies and Reagents Market, by Product

  • Reagent
    • Media & Sera
    • Stains & Dyes
    • Fixatives
    • Buffers
    • Solvents
    • Enzymes
    • Probes
    • Other Reagents
  • Antibodies
    • By Type
      • Primary Antibodies
      • Secondary Antibodies
    • By Form
      • Monoclonal
      • Polyclonal
      • Recombinant
    • By Source
      • Mice
      • Rabbits
      • Other Sources
    • By Research Area
      • Oncology
      • Infectious Diseases
      • Immunology
      • Neurobiology
      • Stem Cells
      • Other Research Areas

Global Research Antibodies and Reagents Market, by Technology

  • Western Blotting
  • Flow Cytometry
  •  Enzyme-linked immunosorbent assay (ELISA)
  • Immunohistochemistry
  • Immunofluorescence
  • Immunoprecipitation
  • Other Technologies

Global Research Antibodies and Reagents Market, by Application

  • Proteomics
  • Drug Development
  •  Genomics

Global Research Antibodies and Reagents Market, by End User

  • Pharmaceutical & Biotechnologies Industries
  • Academic & Research Institutions
  • Contract Research Organizations

Global Research Antibodies and Reagents Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa

Recent Developments

  • In 2019, Thermo Fisher Scientific (US) acquired Brammer Bio (US) to expand its capacity for manufacturing viral vectors for gene and cell therapies with Brammer Bio’s CDMO facilities. The acquisition was valued at USD 1.7 billion.
  • In 2020, Thermo Fisher Scientific (US) collaborated with Wuxi and Mayo Clinic To secure FDA authorization for testing COVID-19 with ELISA for detecting both IgM and IgG antibodies
  • In 2020, Merck (Germany) partnered with Elypta (Sweden) to provide contract manufacturing services for Elypta’s clinical diagnostic liquid biopsy kits
  • In 2020, Abcam (UK) acquired Marker Gene Technologies (US) To extend Abcam’s assay and labeling capabilities

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 34)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS
           1.2.2 MARKETS COVERED
                 FIGURE 1 GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET
           1.2.3 YEARS CONSIDERED FOR THE STUDY
    1.3 CURRENCY
    1.4 STAKEHOLDERS
    1.5 LIMITATIONS
    1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 38)
    2.1 RESEARCH APPROACH
        FIGURE 2 RESEARCH DESIGN
           2.1.1 SECONDARY RESEARCH
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY RESEARCH
                 FIGURE 3 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Breakdown of primaries
                            FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATIONS, AND REGION
    2.2 MARKET SIZE ESTIMATION
        FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
        FIGURE 6 MARKET SIZING FROM COMPANY REVENUE
        FIGURE 7 MARKET ANALYSIS APPROACH
        FIGURE 8 TOP-DOWN APPROACH
    2.3 DATA TRIANGULATION APPROACH
        FIGURE 9 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE ESTIMATION
    2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. - 48)
  FIGURE 10 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
  FIGURE 11 RESEARCH ANTIBODIES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
  FIGURE 12 RESEARCH REAGENTS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
  FIGURE 13 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2020 VS. 2025 (USD MILLION)
  FIGURE 14 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
  FIGURE 15 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
  FIGURE 16 GEOGRAPHIC ANALYSIS: RESEARCH ANTIBODIES AND REAGENTS MARKET

4 PREMIUM INSIGHTS (Page No. - 53)
    4.1 RESEARCH ANTIBODIES AND REAGENTS: MARKET OVERVIEW
        FIGURE 17 INCREASING R&D EXPENDITURE IN THE LIFE SCIENCE INDUSTRY TO DRIVE MARKET GROWTH
    4.2 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION
        FIGURE 18 PROTEOMICS ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC RESEARCH ANTIBODIES AND REAGENTS MARKET IN 2019
    4.3 RESEARCH ANTIBODIES AND REAGENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
        FIGURE 19 CHINA SHOWS THE HIGHEST REVENUE GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD
    4.4 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY REGION (2018–2025)
        FIGURE 20 NORTH AMERICA WILL CONTINUE TO DOMINATE THE RESEARCH ANTIBODIES AND REAGENTS MARKET UNTIL 2025
    4.5 RESEARCH ANTIBODIES AND REAGENTS MARKET: DEVELOPED VS. DEVELOPING MARKETS
        FIGURE 21 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE IN THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 57)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
        FIGURE 22 RESEARCH ANTIBODIES AND REAGENTS MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Increasing research activity and funding for R&D
                    5.2.1.2 Growing industry-academia collaboration
                            TABLE 1 KEY MARKET DRIVERS: IMPACT ANALYSIS
           5.2.2 RESTRAINTS
                    5.2.2.1 Quality concerns and a lack of reproducible results
                            TABLE 2 KEY MARKET RESTRAINTS: IMPACT ANALYSIS
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Emerging markets
                    5.2.3.2 Personalized medicine and protein therapeutics
                            FIGURE 23 NUMBER OF PERSONALIZED MEDICINE PRODUCTS, 2008–2016
                    5.2.3.3 Growth in stem cell and neurobiology research
                    5.2.3.4 Increasing focus on biomarker discovery
                    5.2.3.5 Rising interest in outsourcing
                            TABLE 3 KEY MARKET OPPORTUNITIES: IMPACT ANALYSIS
           5.2.4 CHALLENGES
                    5.2.4.1 Cost and time-intensive antibody development processes
                    5.2.4.2 Pricing pressure faced by prominent market players
                            TABLE 4 KEY MARKET CHALLENGES: IMPACT ANALYSIS

6 INDUSTRY INSIGHTS (Page No. - 64)
    6.1 INTRODUCTION
    6.2 INDUSTRY TRENDS
           6.2.1 INCREASING RESEARCH ON THERAPEUTIC ANTIBODIES
           6.2.2 RECOMBINANT ANTIBODIES ARE SUPPORTING THE SMOOTH TRANSITION FROM IN VITRO TO IN VIVO
           6.2.3 GROWING CONSOLIDATION OF THE LIFE SCIENCE ANTIBODIES AND REAGENTS MARKET
                 TABLE 5 MAJOR ACQUISITIONS IN THE RESEARCH ANTIBODIES AND REAGENTS MARKET
    6.3 STAKEHOLDER ANALYSIS
        FIGURE 24 RESEARCH ANTIBODIES AND REAGENTS MARKETS: STAKEHOLDER ANALYSIS (2019)
    6.4 STRATEGIC BENCHMARKING
        TABLE 6 PRODUCT PORTFOLIO ANALYSIS
    6.5 IMPACT OF COVID-19 ON THE RESEARCH ANTIBODIES AND REAGENTS MARKET

7 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT (Page No. - 70)
    7.1 INTRODUCTION
        TABLE 7 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
    7.2 REAGENTS
        TABLE 8 REAGENTS, BY TYPE
        TABLE 9 RESEARCH REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 10 RESEARCH REAGENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           7.2.1 MEDIA & SERA
                    7.2.1.1 Media & sera hold the largest share of the reagents market
                            TABLE 11 RESEARCH REAGENTS MARKET FOR MEDIA & SERA, BY COUNTRY, 2018–2025 (USD MILLION)
           7.2.2 STAINS & DYES
                    7.2.2.1 Growth of the life science industry is driving the demand and use of stains & dyes
                            TABLE 12 RESEARCH REAGENTS MARKET FOR STAINS & DYES, BY COUNTRY, 2018–2025 (USD MILLION)
           7.2.3 FIXATIVES
                    7.2.3.1 Fixative agents are needed to preserve the morphology and antigenicity of target molecules
                            TABLE 13 RESEARCH REAGENTS MARKET FOR FIXATIVES, BY COUNTRY, 2018–2025 (USD MILLION)
           7.2.4 BUFFERS
                    7.2.4.1 Wide use in drug development will drive the market for buffers
                            TABLE 14 RESEARCH REAGENTS MARKET FOR BUFFERS, BY COUNTRY, 2018–2025 (USD MILLION)
           7.2.5 SOLVENTS
                    7.2.5.1 Organic solvents see wide use in pharmaceutical processes and assays like IHC
                            TABLE 15 RESEARCH REAGENTS MARKET FOR SOLVENTS, BY COUNTRY, 2018–2025 (USD MILLION)
           7.2.6 ENZYMES
                    7.2.6.1 An increase in proteomic and genomic research activity will ensure demand for enzymes
                            TABLE 16 RESEARCH REAGENTS MARKET FOR ENZYMES, BY COUNTRY, 2018–2025 (USD MILLION)
           7.2.7 PROBES
                    7.2.7.1 The versatility, sensitivity, and quantitative capabilities of probes have ensured their use in research
                            TABLE 17 RESEARCH REAGENTS MARKET FOR PROBES, BY COUNTRY, 2018–2025 (USD MILLION)
           7.2.8 OTHER REAGENTS
                 TABLE 18 OTHER RESEARCH REAGENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
    7.3 ANTIBODIES
        TABLE 19 RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           7.3.1 ANTIBODIES, BY TYPE
                 TABLE 20 ANTIBODIES, BY TYPE
                 TABLE 21 RESEARCH ANTIBODIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                    7.3.1.1 Primary antibodies
                               7.3.1.1.1 Increasing demand for accurate and reliable antibodies follows the rise in R&D activity and expenditure
                                         TABLE 22 PRIMARY RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
                    7.3.1.2 Secondary antibodies
                               7.3.1.2.1 Versatility and low cost of production have ensured stable growth in the market for secondary antibodies
                                         TABLE 23 SECONDARY RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           7.3.2 ANTIBODIES, BY FORM
                 TABLE 24 ANTIBODIES, BY FORM
                 TABLE 25 RESEARCH ANTIBODIES MARKET, BY FORM, 2018–2025 (USD MILLION)
                    7.3.2.1 Monoclonal antibodies
                               7.3.2.1.1 Monoclonal antibodies are among the most common tools in biomedical science
                                         TABLE 26 MONOCLONAL RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
                    7.3.2.2 Polyclonal antibodies
                               7.3.2.2.1 Thermo Fisher Scientific and Abcam are major players in the polyclonal antibodies market
                                         TABLE 27 POLYCLONAL RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
                    7.3.2.3 Recombinant antibodies
                               7.3.2.3.1 Recombinant antibodies provide a high-specificity, high-sensitivity option
                                         TABLE 28 RECOMBINANT RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           7.3.3 ANTIBODIES, BY SOURCE
                 TABLE 29 ANTIBODIES, BY SOURCE
                 TABLE 30 RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018–2025 (USD MILLION)
                    7.3.3.1 Mice
                               7.3.3.1.1 Mice are the preferred hosts for research-use antibody production
                                         TABLE 31 MOUSE ANTIBODIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
                    7.3.3.2 Rabbits
                               7.3.3.2.1 Rabbits are a cost-effective means of antibody production
                                         TABLE 32 RABBIT ANTIBODIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
                    7.3.3.3 Other sources
                            TABLE 33 OTHER ANTIBODY SOURCES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           7.3.4 ANTIBODIES, BY RESEARCH AREA
                 TABLE 34 ANTIBODIES, BY RESEARCH AREA
                 TABLE 35 RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018–2025 (USD MILLION)
                    7.3.4.1 Oncology
                               7.3.4.1.1 The high prevalence of cancer has boosted research activity in the sector
                                         TABLE 36 RESEARCH ANTIBODIES MARKET FOR ONCOLOGY, BY COUNTRY, 2018–2025 (USD MILLION)
                    7.3.4.2 Infectious diseases
                               7.3.4.2.1 Rising awareness and growing research activity are key drivers of the market
                                         TABLE 37 RESEARCH ANTIBODIES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2018–2025 (USD MILLION)
                    7.3.4.3 Immunology
                               7.3.4.3.1 Antibodies are used to identify protein and peptides to understand infectious disease immunology better
                                         TABLE 38 RESEARCH ANTIBODIES MARKET FOR IMMUNOLOGY, BY COUNTRY, 2018–2025 (USD MILLION)
                    7.3.4.4 Neurobiology
                               7.3.4.4.1 Antibody-based approaches are widely used in molecular and cellular neuroscience
                                         TABLE 39 RESEARCH ANTIBODIES MARKET FOR NEUROBIOLOGY, BY COUNTRY, 2018–2025 (USD MILLION)
                    7.3.4.5 Stem cells
                               7.3.4.5.1 Increasing funding and the growing importance of stem cells in transplantation are key market drivers
                                         TABLE 40 RESEARCH ANTIBODIES MARKET FOR STEM CELLS, BY COUNTRY, 2018–2025 (USD MILLION)
                    7.3.4.6 Other research areas
                            TABLE 41 RESEARCH ANTIBODIES MARKET FOR OTHER RESEARCH AREAS, BY COUNTRY, 2018–2025 (USD MILLION)

8 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY (Page No. - 105)
    8.1 INTRODUCTION
        TABLE 42 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
    8.2 WESTERN BLOTTING
           8.2.1 HIGH ACCURACY, EASE OF INTERPRETATION, AND OTHER ADVANTAGES HAVE PROPELLED THE USE OF WESTERN BLOTTING
                 TABLE 43 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR WESTERN BLOTTING, BY COUNTRY, 2018–2025 (USD MILLION)
    8.3 FLOW CYTOMETRY
           8.3.1 FLOW CYTOMETRY IS THE FASTEST-GROWING TECHNOLOGY SEGMENT OF THE MARKET
                 TABLE 44 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2018–2025 (USD MILLION)
    8.4 ENZYME-LINKED IMMUNOSORBENT ASSAY
           8.4.1 ELISA HAS THE POTENTIAL TO SUPERSEDE THE CURRENT GOLD STANDARD FOR COVID-19 TESTING
                 TABLE 45 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR ELISA, BY COUNTRY, 2018–2025 (USD MILLION)
    8.5 IMMUNOHISTOCHEMISTRY
           8.5.1 COMPLEXITIES OF IHC POSE CHALLENGES TO MARKET GROWTH
                 TABLE 46 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2018–2025 (USD MILLION)
    8.6 IMMUNOFLUORESCENCE
           8.6.1 IMMUNOFLUORESCENCE HELPS DETERMINE SPECIFIC GENE EXPRESSIONS
                 TABLE 47 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2018–2025 (USD MILLION)
    8.7 IMMUNOPRECIPITATION
           8.7.1 RESULTS OBTAINED BY IP CAN BE ANALYZED THROUGH OTHER TECHNOLOGIES
                 TABLE 48 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR IMMUNOPRECIPITATION, BY COUNTRY, 2018–2025 (USD MILLION)
    8.8 OTHER TECHNOLOGIES
        TABLE 49 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2018–2025 (USD MILLION)

9 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION (Page No. - 116)
    9.1 INTRODUCTION
        TABLE 50 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
    9.2 PROTEOMICS
           9.2.1 PROTEOMICS HOLDS THE LARGEST SHARE OF THE MARKET, BY APPLICATION
                 TABLE 51 TECHNOLOGICAL APPLICATIONS OF ANTIBODIES IN PROTEOMICS
                 TABLE 52 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR PROTEOMICS, BY COUNTRY, 2018–2025 (USD MILLION)
    9.3 DRUG DEVELOPMENT
           9.3.1 THE DRUG DEVELOPMENT APPLICATIONS SEGMENT IS EXPECTED TO GROW AT THE HIGHEST RATE
                 FIGURE 25 APPLICATION OF ANTIBODIES IN THE DRUG DEVELOPMENT PROCESS
                 TABLE 53 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR DRUG DEVELOPMENT, BY COUNTRY, 2018–2025 (USD MILLION)
    9.4 GENOMICS
           9.4.1 GENOMICS IS CURRENTLY AN EMERGING AREA OF RESEARCH APPLICATIONS AND EXPECTED TO SEE GROWTH IN THE COMING YEARS
                 TABLE 54 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR GENOMICS, BY COUNTRY, 2018–2025 (USD MILLION)

10 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER (Page No. - 123)
     10.1 INTRODUCTION
                    TABLE 55 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018–2025 (USD MILLION)
     10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
             10.2.1 PHARMA & BIOTECH COMPANIES DOMINATE THE END-USER MARKET
                    TABLE 56 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
     10.3 ACADEMIC & RESEARCH INSTITUTIONS
             10.3.1 GROWING GOVERNMENT INVESTMENTS TO PROPEL THE MARKET
                    TABLE 57 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2018–2025 (USD MILLION)
     10.4 CONTRACT RESEARCH ORGANIZATIONS
             10.4.1 GROWING WORK ON MONOCLONAL ANTIBODIES AND DRUG CONJUGATES AMONG CROS IS AIDING MARKET GROWTH
                    TABLE 58 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION)

11 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY REGION (Page No. - 128)
     11.1 INTRODUCTION
          FIGURE 26 RESEARCH ANTIBODIES AND REAGENTS MARKET: GEOGRAPHIC SNAPSHOT (2019)
          TABLE 59 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
     11.2 NORTH AMERICA
          FIGURE 27 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET SNAPSHOT
          TABLE 60 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
          TABLE 61 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
          TABLE 62 NORTH AMERICA: RESEARCH REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
          TABLE 63 NORTH AMERICA: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
          TABLE 64 NORTH AMERICA: RESEARCH ANTIBODIES MARKET, BY FORM, 2018–2025 (USD MILLION)
          TABLE 65 NORTH AMERICA: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018–2025 (USD MILLION)
          TABLE 66 NORTH AMERICA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018–2025 (USD MILLION)
          TABLE 67 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
          TABLE 68 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
          TABLE 69 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018–2025 (USD MILLION)
             11.2.1 US
                        11.2.1.1 The US dominates the North American market in terms of market share
                                 TABLE 70 US NIH BUDGET FOR VARIOUS DISCIPLINES, FY 2019 VS. FY 2020 (USD BILLION)
                                 TABLE 71 US: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                 TABLE 72 US: RESEARCH REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 73 US: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 74 US: RESEARCH ANTIBODIES MARKET, BY FORM, 2018–2025 (USD MILLION)
                                 TABLE 75 US: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018–2025 (USD MILLION)
                                 TABLE 76 US: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018–2025 (USD MILLION)
                                 TABLE 77 US: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
                                 TABLE 78 US: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
                                 TABLE 79 US: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018–2025 (USD MILLION)
             11.2.2 CANADA
                        11.2.2.1 Rising cancer incidence and a favorable funding scenario will push market growth in Canada
                                 TABLE 80 CANADA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                 TABLE 81 CANADA: RESEARCH REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 82 CANADA: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 83 CANADA: RESEARCH ANTIBODIES MARKET, BY FORM, 2018–2025 (USD MILLION)
                                 TABLE 84 CANADA: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018–2025 (USD MILLION)
                                 TABLE 85 CANADA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018–2025 (USD MILLION)
                                 TABLE 86 CANADA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
                                 TABLE 87 CANADA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
                                 TABLE 88 CANADA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018–2025 (USD MILLION)
     11.3 EUROPE
          FIGURE 28 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET SNAPSHOT
          TABLE 89 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
          TABLE 90 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
          TABLE 91 EUROPE: RESEARCH REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
          TABLE 92 EUROPE: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
          TABLE 93 EUROPE: RESEARCH ANTIBODIES MARKET, BY FORM, 2018–2025 (USD MILLION)
          TABLE 94 EUROPE: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018–2025 (USD MILLION)
          TABLE 95 EUROPE: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018–2025 (USD MILLION)
          TABLE 96 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
          TABLE 97 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET,  BY APPLICATION, 2018–2025 (USD MILLION)
          TABLE 98 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018–2025 (USD MILLION)
             11.3.1 GERMANY
                        11.3.1.1 German holds the largest share of the market in Europe
                                 TABLE 99 GERMANY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                 TABLE 100 GERMANY: RESEARCH REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 101 GERMANY: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 102 GERMANY: RESEARCH ANTIBODIES MARKET, BY FORM, 2018–2025 (USD MILLION)
                                 TABLE 103 GERMANY: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018–2025 (USD MILLION)
                                 TABLE 104 GERMANY: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018–2025 (USD MILLION)
                                 TABLE 105 GERMANY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
                                 TABLE 106 GERMANY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
                                 TABLE 107 GERMANY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018–2025 (USD MILLION)
             11.3.2 UK
                        11.3.2.1 The market in the UK is characterized by expansions by leading players and growing R&D investments
                                 TABLE 108 UK: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                 TABLE 109 UK: RESEARCH REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 110 UK: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 111 UK: RESEARCH ANTIBODIES MARKET, BY FORM, 2018–2025 (USD MILLION)
                                 TABLE 112 UK: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018–2025 (USD MILLION)
                                 TABLE 113 UK: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018–2025 (USD MILLION)
                                 TABLE 114 UK: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
                                 TABLE 115 UK: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
                                 TABLE 116 UK: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER,  2018 –2025 (USD MILLION)
             11.3.3 FRANCE
                        11.3.3.1 Infrastructural development and rising research activity support market growth in France
                                 TABLE 117 FRANCE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                 TABLE 118 FRANCE: RESEARCH REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 119 FRANCE: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 120 FRANCE: RESEARCH ANTIBODIES MARKET, BY FORM, 2018–2025 (USD MILLION)
                                 TABLE 121 FRANCE: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018–2025 (USD MILLION)
                                 TABLE 122 FRANCE: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018–2025 (USD MILLION)
                                 TABLE 123 FRANCE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
                                 TABLE 124 FRANCE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
                                 TABLE 125 FRANCE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018–2025 (USD MILLION)
             11.3.4 ITALY
                        11.3.4.1 Rising life science R&D and favorable funding scenario are key drivers of the Italian market
                                 TABLE 126 ITALY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                 TABLE 127 ITALY: RESEARCH REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 128 ITALY: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 129 ITALY: RESEARCH ANTIBODIES MARKET, BY FORM, 2018–2025 (USD MILLION)
                                 TABLE 130 ITALY: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018–2025 (USD MILLION)
                                 TABLE 131 ITALY: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018–2025 (USD MILLION)
                                 TABLE 132 ITALY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
                                 TABLE 133 ITALY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
                                 TABLE 134 ITALY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018–2025 (USD MILLION)
             11.3.5 SPAIN
                        11.3.5.1 Favorable scenario for research initiatives drives the market in Spain
                                 TABLE 135 SPAIN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                 TABLE 136 SPAIN: RESEARCH REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 137 SPAIN: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 138 SPAIN: RESEARCH ANTIBODIES MARKET, BY FORM, 2018–2025 (USD MILLION)
                                 TABLE 139 SPAIN: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018–2025 (USD MILLION)
                                 TABLE 140 SPAIN: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018–2025 (USD MILLION)
                                 TABLE 141 SPAIN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
                                 TABLE 142 SPAIN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
                                 TABLE 143 SPAIN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018–2025 (USD MILLION)
             11.3.6 REST OF EUROPE
                    TABLE 144 REST OF EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                    TABLE 145 REST OF EUROPE: RESEARCH REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                    TABLE 146 REST OF EUROPE: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                    TABLE 147 REST OF EUROPE: RESEARCH ANTIBODIES MARKET, BY FORM, 2018–2025 (USD MILLION)
                    TABLE 148 REST OF EUROPE: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018–2025 (USD MILLION)
                    TABLE 149 REST OF EUROPE: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018–2025 (USD MILLION)
                    TABLE 150 REST OF EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET,  BY TECHNOLOGY, 2018–2025 (USD MILLION)
                    TABLE 151 REST OF EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
                    TABLE 152 REST OF EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018–2025 (USD MILLION)
     11.4 ASIA PACIFIC
          FIGURE 29 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET SNAPSHOT
          TABLE 153 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
          TABLE 154 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
          TABLE 155 ASIA PACIFIC: RESEARCH REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
          TABLE 156 ASIA PACIFIC: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
          TABLE 157 ASIA PACIFIC: RESEARCH ANTIBODIES MARKET, BY FORM, 2018–2025 (USD MILLION)
          TABLE 158 ASIA PACIFIC: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018–2025 (USD MILLION)
          TABLE 159 ASIA PACIFIC: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018–2025 (USD MILLION)
          TABLE 160 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
          TABLE 161 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
          TABLE 162 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET,  BY END USER, 2018–2025 (USD MILLION)
             11.4.1 JAPAN
                        11.4.1.1 Japan dominates the APAC market
                                 TABLE 163 JAPAN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                 TABLE 164 JAPAN: RESEARCH REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 165 JAPAN: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 166 JAPAN: RESEARCH ANTIBODIES MARKET, BY FORM, 2018–2025 (USD MILLION)
                                 TABLE 167 JAPAN: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018–2025 (USD MILLION)
                                 TABLE 168 JAPAN: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018–2025 (USD MILLION)
                                 TABLE 169 JAPAN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
                                 TABLE 170 JAPAN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
                                 TABLE 171 JAPAN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018–2025 (USD MILLION)
             11.4.2 CHINA
                        11.4.2.1 China is the fastest-growing segment of the overall market
                                 TABLE 172 CHINA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                 TABLE 173 CHINA: RESEARCH REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 174 CHINA: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 175 CHINA: RESEARCH ANTIBODIES MARKET, BY FORM, 2018–2025 (USD MILLION)
                                 TABLE 176 CHINA: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018–2025 (USD MILLION)
                                 TABLE 177 CHINA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018–2025 (USD MILLION)
                                 TABLE 178 CHINA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
                                 TABLE 179 CHINA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
                                 TABLE 180 CHINA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018–2025 (USD MILLION)
             11.4.3 INDIA
                        11.4.3.1 Strong economic growth and rising demand for pharmaceuticals are key market drivers in India
                                 TABLE 181 INDIA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                 TABLE 182 INDIA: RESEARCH REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 183 INDIA: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 184 INDIA: RESEARCH ANTIBODIES MARKET, BY FORM, 2018–2025 (USD MILLION)
                                 TABLE 185 INDIA: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018–2025 (USD MILLION)
                                 TABLE 186 INDIA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018–2025 (USD MILLION)
                                 TABLE 187 INDIA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
                                 TABLE 188 INDIA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
                                 TABLE 189 INDIA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018–2025 (USD MILLION)
             11.4.4 REST OF ASIA PACIFIC
                    TABLE 190 ROAPAC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                    TABLE 191 ROAPAC: RESEARCH REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                    TABLE 192 ROAPAC: RESEARCH ANTIBODIES MARKET, BY TYPE,  2018–2025 (USD MILLION)
                    TABLE 193 ROAPAC: RESEARCH ANTIBODIES MARKET, BY FORM, 2018–2025 (USD MILLION)
                    TABLE 194 ROAPAC: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018–2025 (USD MILLION)
                    TABLE 195 ROAPAC: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA,  2018–2025 (USD MILLION)
                    TABLE 196 ROAPAC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
                    TABLE 197 ROAPAC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
                    TABLE 198 ROAPAC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018–2025 (USD MILLION)
     11.5 LATIN AMERICA
             11.5.1 BRAZIL AND MEXICO TO GROW AT HIGH RATES IN THE LATAM MARKET
                    TABLE 199 LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                    TABLE 200 LATIN AMERICA: RESEARCH REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                    TABLE 201 LATIN AMERICA: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                    TABLE 202 LATIN AMERICA: RESEARCH ANTIBODIES MARKET, BY FORM, 2018–2025 (USD MILLION)
                    TABLE 203 LATIN AMERICA: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018–2025 (USD MILLION)
                    TABLE 204 LATIN AMERICA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018–2025 (USD MILLION)
                    TABLE 205 LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
                    TABLE 206 LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
                    TABLE 207 LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018–2025 (USD MILLION)
     11.6 MIDDLE EAST AND AFRICA
             11.6.1 MEA HOLDS THE SMALLEST SHARE OF THE MARKET BUT IS EXPECTED TO PROVIDE STRONG GROWTH OPPORTUNITIES
                    TABLE 208 MEA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                    TABLE 209 MEA: RESEARCH REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                    TABLE 210 MEA: RESEARCH ANTIBODIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                    TABLE 211 MEA: RESEARCH ANTIBODIES MARKET, BY FORM, 2018–2025 (USD MILLION)
                    TABLE 212 MEA: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2018–2025 (USD MILLION)
                    TABLE 213 MEA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2018–2025 (USD MILLION)
                    TABLE 214 MEA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
                    TABLE 215 MEA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
                    TABLE 216 MEA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2018–2025 (USD MILLION)

12 COMPETITIVE LANDSCAPE (Page No. - 198)
     12.1 OVERVIEW
     12.2 MATRIX EVALUATION FRAMEWORK
          FIGURE 30 MATRIX EVALUATION FRAMEWORK: ACQUISITION WAS THE MOST-ADOPTED STRATEGY
     12.3 RESEARCH ANTIBODIES MARKET SHARE ANALYSIS
          FIGURE 31 GLOBAL RESEARCH ANTIBODIES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019
     12.4 COMPETITIVE LEADERSHIP MAPPING
             12.4.1 STARS
             12.4.2 EMERGING LEADERS
             12.4.3 PERVASIVE COMPANIES
             12.4.4 EMERGING COMPANIES
                    FIGURE 32 COMPETITIVE LEADERSHIP MAPPING (2019)
     12.5 COMPETITIVE SITUATION AND TRENDS
             12.5.1 PRODUCT LAUNCHES
                    TABLE 217 KEY PRODUCT LAUNCHES, 2020
             12.5.2 EXPANSIONS
                    TABLE 218 KEY EXPANSIONS, 2018–2020
             12.5.3 ACQUISITIONS
                    TABLE 219 KEY ACQUISITIONS, 2019–2020
             12.5.4 COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS
                    TABLE 220 COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS, 2019–2020

13 COMPANY PROFILES (Page No. - 206)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
     13.1 THERMO FISHER SCIENTIFIC
          FIGURE 33 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019)
     13.2 MERCK GROUP
          FIGURE 34 MERCK GROUP: COMPANY SNAPSHOT (2019)
     13.3 ABCAM PLC
          FIGURE 35 ABCAM PLC: COMPANY SNAPSHOT (2019)
     13.4 BECTON, DICKINSON AND COMPANY
          FIGURE 36 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019)
     13.5 CELL SIGNALING TECHNOLOGY
     13.6 BIO-RAD LABORATORIES
          FIGURE 37 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2019)
     13.7 F. HOFFMANN-LA ROCHE
          FIGURE 38 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2019)
     13.8 AGILENT TECHNOLOGIES
          FIGURE 39 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2019)
     13.9 DANAHER CORPORATION
          FIGURE 40 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
     13.10 LONZA
           FIGURE 41 LONZA: COMPANY SNAPSHOT (2019)
     13.11 GENSCRIPT
           FIGURE 42 GENSCRIPT: COMPANY SNAPSHOT (2019)
     13.12 PERKINELMER
           FIGURE 43 PERKINELMER: COMPANY SNAPSHOT (2019)
     13.13 BIOLEGEND
     13.14 ILLUMINA
           FIGURE 44 ILLUMINA: COMPANY SNAPSHOT (2019)
     13.15 IMMUNOPRECISE ANTIBODIES
           FIGURE 45 IMMUNOPRECISE ANTIBODIES: COMPANY SNAPSHOT (2019)
     13.16 FUJIREBIO DIAGNOSTICS AB
     13.17 ANALYTIK JENA AG
     13.18 OMEGA BIO-TEK
     13.19 DOVETAIL GENOMICS
     13.20 ATLAS ANTIBODIES

*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

14 APPENDIX (Page No. - 268)
     14.1 INSIGHTS OF INDUSTRY EXPERTS
     14.2 DISCUSSION GUIDE
     14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     14.4 AVAILABLE CUSTOMIZATIONS
     14.5 RELATED REPORTS
     14.6 AUTHOR DETAILS

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

This research study involved the use of widespread secondary sources; directories; databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva; white papers; annual reports; and companies’ house documents. Secondary research was used to identify and collect information for this extensive, technical, market-oriented, and commercial study of the global research antibodies and reagents market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, key developments related to market, and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side included industry experts, such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the global research antibodies and reagents market. The primary sources from the demand side included industry experts, such as life science researchers.

A breakdown of the primary respondents is provided below:

Research Antibodies & Reagents Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by product, technology, application, end user, and region).

Data Triangulation

After arriving at the market size, the research antibodies and reagents market was divided into several segments and sub segments. To complete the overall market engineering process and arrive at the exact statistics for all segments & sub segments, the data triangulation and market breakdown procedures were employed, wherever applicable.

Objectives of the Study

  • To define, describe, segment, and forecast the global research antibodies and reagents market based on the product, technology, application, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and industry-specific challenges)
  • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze the market opportunities for stakeholders and provide details of the competitive landscape for market players
  • To forecast the size of the global research antibodies and reagents market in five main regions (along with countries)—North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East and Africa (MEA)
  • To profile key players in the global research antibodies and reagents market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments, such as product/technology development, partnerships, mergers, acquisitions, and expansions, and the R&D activities of the leading players in the research antibodies and reagents market
  • To benchmark players within the research antibodies and reagents market using the "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (Upto 5)

Geographic Analysis

  • Further breakdown of the Rest of Asia Pacific market into South Korea, Australia, New Zealand, and other Asian countries
  • Further breakdown of the Latin American market into Brazil, Argentina, and other Latin American countries
COVID-19

Get in-depth analysis of the COVID-19 impact on the Research Antibodies & Reagents Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Research Antibodies & Reagents Market

Request For Special Pricing
Report Code
BT 5482
Published ON
Oct, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Research Antibodies & Reagents Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2020 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home